Mounjaro

Key Features

Mounjaro (tirzepatide) is an injectable, pre-filled pen used to manage type 2 diabetes. It is administered as a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm. The starting dose is 2.5 mg once weekly for four weeks, with the dosage increasing gradually by 2.5 mg every four weeks as tolerated. The maximum dose is 15 mg once weekly.

Benefits

Mounjaro works by increasing insulin levels when blood glucose is high, preventing the release of stored sugar from the liver, and slowing down the absorption of food and drink. In addition to helping to control blood sugar, it also assists with weight loss, improved insulin sensitivity, and appetite suppression. Mounjaro also helps with long-term blood glucose control and can improve heart function and reduce blood pressure.